CN102558273A - 氟替卡松糠酸酯的制备方法 - Google Patents
氟替卡松糠酸酯的制备方法 Download PDFInfo
- Publication number
- CN102558273A CN102558273A CN2010105881661A CN201010588166A CN102558273A CN 102558273 A CN102558273 A CN 102558273A CN 2010105881661 A CN2010105881661 A CN 2010105881661A CN 201010588166 A CN201010588166 A CN 201010588166A CN 102558273 A CN102558273 A CN 102558273A
- Authority
- CN
- China
- Prior art keywords
- reaction
- alpha
- compound
- iii
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
- C07J71/0015—Oxiranes at position 9(11)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010588166.1A CN102558273B (zh) | 2010-12-14 | 2010-12-14 | 氟替卡松糠酸酯的制备方法 |
PCT/CN2011/001146 WO2012079275A1 (zh) | 2010-12-14 | 2011-07-11 | 氟替卡松糠酸酯的制备方法 |
US13/913,378 US8969547B2 (en) | 2010-12-14 | 2013-06-07 | Method for preparing fluticasone furoate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010588166.1A CN102558273B (zh) | 2010-12-14 | 2010-12-14 | 氟替卡松糠酸酯的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102558273A true CN102558273A (zh) | 2012-07-11 |
CN102558273B CN102558273B (zh) | 2014-07-02 |
Family
ID=46244010
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201010588166.1A Active CN102558273B (zh) | 2010-12-14 | 2010-12-14 | 氟替卡松糠酸酯的制备方法 |
Country Status (3)
Country | Link |
---|---|
US (1) | US8969547B2 (zh) |
CN (1) | CN102558273B (zh) |
WO (1) | WO2012079275A1 (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110105418A (zh) * | 2019-05-22 | 2019-08-09 | 博诺康源(北京)药业科技有限公司 | 一种糠酸氟替卡松原料药杂质的制备和纯化方法 |
CN111380969A (zh) * | 2018-12-29 | 2020-07-07 | 天津药业研究院有限公司 | 一种糠酸氟替卡松含量和有关物质的检测方法 |
CN111662353A (zh) * | 2019-03-05 | 2020-09-15 | 上海谷森医药有限公司 | 一种糠酸氟替卡松晶型1的制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4335121A (en) * | 1980-02-15 | 1982-06-15 | Glaxo Group Limited | Androstane carbothioates |
WO2001062722A2 (en) * | 2000-02-25 | 2001-08-30 | Abbott Laboratories | Method for the preparation of fluticasone and related 17beta-carbothioic esters using a novel carbothioic acid synthesis and novel purification methods |
CN1680423A (zh) * | 2000-08-05 | 2005-10-12 | 葛兰素集团有限公司 | 作为抗炎剂的雄甾烷系列化合物的中间体及其制备方法 |
CN100999541A (zh) * | 2006-12-19 | 2007-07-18 | 高邮市兆康制药有限公司 | 丙酸氟替卡松的合成方法 |
WO2007144363A2 (en) * | 2006-06-16 | 2007-12-21 | Glaxo Group Limited | Process for the preparation of 6-alpha, 9-alpha-difluoro-17-alpha - ((2-furanylcarbonyl)oxy)-11-beta -hydroxy-16-alpha -methyl-s-oxo-androsta-1,4-diene-17-beta- -carbothioic acid s-fluoromethyl |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CY1291A (en) | 1980-02-15 | 1985-10-18 | Glaxo Group Ltd | Androstane 17 beta carbothioates |
US6759398B2 (en) * | 2000-08-05 | 2004-07-06 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative |
JP2005522442A (ja) * | 2002-02-04 | 2005-07-28 | グラクソ グループ リミテッド | 非晶質フルチカゾン2−フロエート、その医薬組成物およびその結晶非溶媒和形態への変換 |
-
2010
- 2010-12-14 CN CN201010588166.1A patent/CN102558273B/zh active Active
-
2011
- 2011-07-11 WO PCT/CN2011/001146 patent/WO2012079275A1/zh active Application Filing
-
2013
- 2013-06-07 US US13/913,378 patent/US8969547B2/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4335121A (en) * | 1980-02-15 | 1982-06-15 | Glaxo Group Limited | Androstane carbothioates |
WO2001062722A2 (en) * | 2000-02-25 | 2001-08-30 | Abbott Laboratories | Method for the preparation of fluticasone and related 17beta-carbothioic esters using a novel carbothioic acid synthesis and novel purification methods |
CN1680423A (zh) * | 2000-08-05 | 2005-10-12 | 葛兰素集团有限公司 | 作为抗炎剂的雄甾烷系列化合物的中间体及其制备方法 |
WO2007144363A2 (en) * | 2006-06-16 | 2007-12-21 | Glaxo Group Limited | Process for the preparation of 6-alpha, 9-alpha-difluoro-17-alpha - ((2-furanylcarbonyl)oxy)-11-beta -hydroxy-16-alpha -methyl-s-oxo-androsta-1,4-diene-17-beta- -carbothioic acid s-fluoromethyl |
CN100999541A (zh) * | 2006-12-19 | 2007-07-18 | 高邮市兆康制药有限公司 | 丙酸氟替卡松的合成方法 |
Non-Patent Citations (1)
Title |
---|
殷莉梅 等: "丙酸氟替卡松的合成工艺改进", 《中国药物化学杂志》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111380969A (zh) * | 2018-12-29 | 2020-07-07 | 天津药业研究院有限公司 | 一种糠酸氟替卡松含量和有关物质的检测方法 |
CN111662353A (zh) * | 2019-03-05 | 2020-09-15 | 上海谷森医药有限公司 | 一种糠酸氟替卡松晶型1的制备方法 |
CN110105418A (zh) * | 2019-05-22 | 2019-08-09 | 博诺康源(北京)药业科技有限公司 | 一种糠酸氟替卡松原料药杂质的制备和纯化方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102558273B (zh) | 2014-07-02 |
US8969547B2 (en) | 2015-03-03 |
US20130274461A1 (en) | 2013-10-17 |
WO2012079275A1 (zh) | 2012-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100560598C (zh) | 氟替卡松丙酸酯的合成方法 | |
CN106279340A (zh) | 一种合成糠酸莫米松或其一水合物的方法 | |
CN103509075A (zh) | 一种制备二氟泼尼酯的方法 | |
CN102558273B (zh) | 氟替卡松糠酸酯的制备方法 | |
CN102367262B (zh) | 一种氢化可的松的制备方法 | |
CN111518151B (zh) | 一种高纯度氢化可的松的制备方法 | |
CN103601782A (zh) | 醋酸泼尼松或其类似物的制备方法 | |
JP2004504403A (ja) | 中間体6α,9α−ジフルオロ−11β,17α−ジヒドロキシ−16α−メチル−アンドロスタ−1,4−ジエン−3−オン−17β−カルボン酸の製造のための酸化方法 | |
CN102603843B (zh) | 一种地塞米松中间体的制备方法 | |
CN106279341A (zh) | 一种糠酸氟替卡松的制备方法 | |
CN102146113B (zh) | 一种16α-羟基泼尼松龙合成方法 | |
CN102964414A (zh) | 17位甾体羧酸酯的合成方法 | |
CN105884644A (zh) | 一种中性内肽酶抑制剂盐优势形态及其制备方法 | |
CN103665078B (zh) | 一种17α-羟基甾体酯的制备方法 | |
CN109627279A (zh) | 一种活性维生素d3中间体的制备方法 | |
CN114276406B (zh) | 去羟米松中间体的制备方法 | |
CN101759740A (zh) | 一种合成3-α-乙酰氧基-去氧雄甾-5-烯-17-酮的方法 | |
CN103421070A (zh) | 一种改进的孕甾烯类化合物c21-乙酰氧基化方法 | |
CN110256519B (zh) | 一锅法制备醋酸乌利司他的方法 | |
CN110317238B (zh) | 一种糠酸氟替卡松的制备方法 | |
CN110343143B (zh) | 一种丙酸氟替卡松的制备方法 | |
CN107814824B (zh) | 一种醋酸四烯物的制备方法 | |
CN104804055A (zh) | 一种采用硅烷化试剂纯化7-酮石胆酸的方法 | |
CN113072448B (zh) | 一种芳基吉非罗齐衍生物高价碘化合物及其制备方法 | |
NO330859B1 (no) | Framgangsmate for esterifisering av karbothiotisk syre |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20161219 Address after: 317200 Taizhou City, Zhejiang province Tiantai Industrial Park, the eight Patentee after: Zhejiang Tiantai Aurisco Pharmaceutical Limited Address before: 317200 Tiantai Industrial Park, Zhejiang, China, eight Patentee before: Zhejiang Tiantai Aurisco Pharmaceutical Limited Patentee before: Shanghai Aurisco Industry Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CP03 | Change of name, title or address |
Address after: 317200 Zhejiang province Tiantai County eight Longxing Industrial Park Road No. 1 Patentee after: Arcane Pharmaceutical Co., Ltd. Address before: 317200 Taizhou City, Zhejiang province Tiantai Industrial Park, the eight Patentee before: Shanghai Aurisco International Co., Ltd. |
|
CP03 | Change of name, title or address | ||
CP01 | Change in the name or title of a patent holder |
Address after: 317200 Zhejiang province Tiantai County eight Longxing Industrial Park Road No. 1 Patentee after: Arcane pharmaceuticals, Limited by Share Ltd Address before: 317200 Zhejiang province Tiantai County eight Longxing Industrial Park Road No. 1 Patentee before: Arcane Pharmaceutical Co., Ltd. |
|
CP01 | Change in the name or title of a patent holder |